OncologyNCT07532083
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
An observational study of Oncology, run by University of Wisconsin, Madison at 1 site in United States.
Trial summary
The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Oncology
- How many people
- 2,000 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Feb 2026to Jan 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Cancer patients undergoing imaging studies as part of their routine clinical care at UW Health and providers who have access to the scan summary tool.
Who may be able to join
- Age 18 years or older
- Having a current or prior cancer diagnosis (any cancer type)
- Has active access to the UW Health MyChart patient portal.
- Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology.
- Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care.
- Willing and able to complete electronic REDCap surveys.
Show all 12Show fewer
- For interview participation: willing to participate in a 30-45-minute phone or video interview.
- Inclusion Criteria (Provider Participants): Cancer care providers will be eligible to participate in this study if they meet all of the following criteria:
- Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health.
- Involved in reviewing, discussing, or sharing imaging results with patients.
- Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation.
- Willing and able to complete electronic surveys or participate in a brief interview (~30 minutes).
Who cannot join
- Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team.
- Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible.
- For the Patient Interview group only: Patients with radiographic disease progression will be excluded.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
UW Health
Madison, Wisconsin, 53792
About this study
The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.
Read the detailed description
Patient groups: Mixed-method approach to evaluate patient understanding of, and anxiety about, imaging results and communication experience regarding the results before and after implementation of AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
Provider group: Quasi-experimental staircase approach to sequentially roll out the tool to three provider cohorts. All hematology/oncology and gynecology oncology attending providers will be randomized by disease group into three relatively similar-sized cohorts based on group-level scan volumes, regardless of individual provider characteristics or communication style. Subsequent cohorts will be added every two months.
Surveys will be the main method of feedback collection at baseline and after implementation of the AI-assisted, patient-friendly imaging report summaries. Interviews will be conducted in a small subset of subjects.
Primary Objective:
- To evaluate patient comprehension of, and anxiety about, imaging results and communication experience regarding the results before and after implementation of AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
Secondary Objective(s):
- Patient Baseline Survey Objective: To evaluate comprehension of, and anxiety about, imaging results and communication experience regarding the results before the implementation of the AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
- Patient Summary Feedback Survey Objective: To evaluate comprehension of, and anxiety about, imaging results and communication experience regarding the results after the implementation of the AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
- Patient Interview Objectives: To understand the imaging result communication process from the patient's perspective.
- Provider Surveys Objective: The Baseline Survey will assess communication habits and preferences (frequency, method, timing), and perceived impact of the AI-Assisted, Patient-Friendly Imaging Report Summaries on clinical workload, and the Post-Implementation Surveys will evaluate changes in workload perception, satisfaction with the AI-Assisted, Patient-Friendly Imaging Report Summaries, the effectiveness of scan result communication with patients, and attitudes toward the use of AI-assisted material in patient care.
- Conditions
- Oncology
- Keywords
- Patient Care, Patient Communication, AI, Artificial Intelligence, Radiology, Imaging, Summary Reports
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patient Participants | * Patient Baseline Survey (pre-implementation, at least 330 participants, up to 1900) * Patient Interviews (10-20 participants) * Patient Summary Feedback Survey (post-implementation, at least 330 participants, up to 1900) | |
| Provider Participants | * Provider Surveys (baseline, 1 month and 3 month post-implementation, 60 participants) * Provider Interviews (up to 20 participants) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves
Baseline data collected in a 10-15 minute survey from patient participants pre-implementation and in a 10-15 minute survey from patient participants post-implementation.
Measured: up to 15 minutes
Perceived impact of scan-result-related patient queries on Provider Participant workload
Scored from 1 (no impact) to 5 (very frequently), higher scores indicate higher impact on workload. Data collected at baseline (pre-implementation) and 3 months (post-implementation).
Measured: baseline, 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2026
- Study start1 Feb 2026
- Primary completionJan 2027 (estimated)
- Study completionJan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for OncologyStudies of the same condition, open and under way.
- More trials run by University of Wisconsin, MadisonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Wisconsin, Madison
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Toby Campbell, MD, Principal investigator, UW School of Medicine and Public Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07532083
- Sponsor's protocol ID
- 2025-1716
- Other IDs
- UW25122, SMPH/DOM Hemato Med Onc, Protocol Version 4/9/26
- Status last verified
- Apr 2026
- First submitted
- 8 Apr 2026
- Last updated
- 5 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Baumann MR, Barton HJ, Voorheis P, Dahl C, DuBenske L, Commers W, Mast K, Campbell T, Patterson BW, Emamekhoo H. Implementing AI-assisted, patient-friendly imaging report summaries to enhance oncology care delivery: protocol for a randomized mixed-methods quality improvement study. medRxiv [Preprint]. 2026 Oct 7:2026.10.05.26364529. doi: 10.64898/2026.10.05.26364529.
PubMed 42926610
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
- ClinicalTrials.gov ID
- NCT07532083
- Acronym / sponsor ID
- 2025-1716
- Conditions
- Oncology
- Keywords
- Patient Care, Patient Communication, AI, Artificial Intelligence, Radiology, Imaging, Summary Reports
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- University of Wisconsin, MadisonUniversity, hospital or other
- Study start
- 1 Feb 2026 (actual)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- Jan 2027 (estimated)
- First posted
- 15 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.
Detailed description
Patient groups: Mixed-method approach to evaluate patient understanding of, and anxiety about, imaging results and communication experience regarding the results before and after implementation of AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
Provider group: Quasi-experimental staircase approach to sequentially roll out the tool to three provider cohorts. All hematology/oncology and gynecology oncology attending providers will be randomized by disease group into three relatively similar-sized cohorts based on group-level scan volumes, regardless of individual provider characteristics or communication style. Subsequent cohorts will be added every two months.
Surveys will be the main method of feedback collection at baseline and after implementation of the AI-assisted, patient-friendly imaging report summaries. Interviews will be conducted in a small subset of subjects.
Primary Objective:
- To evaluate patient comprehension of, and anxiety about, imaging results and communication experience regarding the results before and after implementation of AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
Secondary Objective(s):
- Patient Baseline Survey Objective: To evaluate comprehension of, and anxiety about, imaging results and communication experience regarding the results before the implementation of the AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
- Patient Summary Feedback Survey Objective: To evaluate comprehension of, and anxiety about, imaging results and communication experience regarding the results after the implementation of the AI-assisted, patient-friendly imaging report summaries that accompany the imaging results.
- Patient Interview Objectives: To understand the imaging result communication process from the patient's perspective.
- Provider Surveys Objective: The Baseline Survey will assess communication habits and preferences (frequency, method, timing), and perceived impact of the AI-Assisted, Patient-Friendly Imaging Report Summaries on clinical workload, and the Post-Implementation Surveys will evaluate changes in workload perception, satisfaction with the AI-Assisted, Patient-Friendly Imaging Report Summaries, the effectiveness of scan result communication with patients, and attitudes toward the use of AI-assisted material in patient care.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient Participants | – | –* Patient Baseline Survey (pre-implementation, at least 330 participants, up to 1900) * Patient Interviews (10-20 participants) * Patient Summary Feedback Survey (post-implementation, at least 330 participants, up to 1900) |
| Provider Participants | – | –* Provider Surveys (baseline, 1 month and 3 month post-implementation, 60 participants) * Provider Interviews (up to 20 participants) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Cancer patients undergoing imaging studies as part of their routine clinical care at UW Health and providers who have access to the scan summary tool.
Key inclusion criteria (12 listed)
- Age 18 years or older
- Having a current or prior cancer diagnosis (any cancer type)
- Has active access to the UW Health MyChart patient portal.
- Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology.
- Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care.
Key exclusion criteria (3 listed)
- Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team.
- Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible.
- For the Patient Interview group only: Patients with radiographic disease progression will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves
Time frame: up to 15 minutes
Baseline data collected in a 10-15 minute survey from patient participants pre-implementation and in a 10-15 minute survey from patient participants post-implementation.
Perceived impact of scan-result-related patient queries on Provider Participant workload
Time frame: baseline, 3 months
Scored from 1 (no impact) to 5 (very frequently), higher scores indicate higher impact on workload. Data collected at baseline (pre-implementation) and 3 months (post-implementation).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2026.
- Derived from this study: PubMed 42926610Baumann MR, Barton HJ, Voorheis P, Dahl C, DuBenske L, Commers W, Mast K, Campbell T, Patterson BW, Emamekhoo H. Implementing AI-assisted, patient-friendly imaging report summaries to enhance oncology care delivery: protocol for a randomized mixed-methods quality improvement study. medRxiv [Preprint]. 2026 Oct 7:2026.10.05.26364529. doi: 10.64898/2026.10.05.26364529.
- Individual participant dataSharing planned: No
Related trials for Oncology
Not yet recruiting
Using e-Technologies to Maximize Physical Activity After Cancer Treatment
Cancer
RecruitingPhase 1
IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
Relapsed Solid Tumor Malignancies, Refractory Solid Tumor Malignancies
RecruitingObservational study
Pharmacogenetic Determinants Of Treatment Response In Children
All Malignancies, Children Being Treated for Catastrophic Illness
RecruitingObservational study
Cancer in Inherited Bone Marrow Failure Syndromes
Diamond Blackfan Anemia, Dyskeratosis Congenita
RecruitingObservational study
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Breast Cancer, Breast Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Toby Campbell, MD principal investigator
UW School of Medicine and Public Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Oncology, run by University of Wisconsin, Madison at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Supportive Oncology (608-263-6002, supportiveoncology@uwcarbone.wisc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves (time frame: up to 15 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07532083, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.